ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Oncology Precision Medicine Market, By Component (Therapeutics, Diagnostics / Testing, Informatics & Decision Support, interoperability tools, Services), By Care Pathway Stage (Risk Assessment & Screening, Diagnosis & Tumor Classification, Therapy Selection, Treatment Monitoring, Recurrence Surveillance / MRD, and Clinical Trial Enrolment & Matching, By Technology (Genomics, Transcriptomics, Gene expression profiling / signatures, Proteomics / Protein biomarkers, Mass spectrometry–based proteomics, Cytogenetics & Structural Variation, Single-cell & spatial,Spatial transcriptomics / multiplex imaging), By Biomarker Type (Genetic biomarkers, Genomic signatures / global markers, Tumor mutational burden, Microsatellite instability, Homologous recombination deficiency, Expression / protein markers, Epigenetic biomarkers, MRD biomarkers), By Sample Type (Tissue-based, Blood-based, Whole blood, Other biofluids, Cytology samples), End User (Hospitals & cancer centers, Diagnostic laboratories, Academic & research institutes, Pharmaceutical & biotech companies, CROs / clinical trial networks, and Payers / HTA bodies), By Cancer Type (Solid Tumors, Hematologic Malignancies, and Rare Cancers / Tumor-agnostic Segments), By Reimbursement & Access Channel (Public Reimbursement, Private Reimbursement, Out-of-pocket / Self-pay, Hybrid coverage models, Patient Assistance / Access Programs, and Clinical trial–funded Testing), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 09 Feb, 2026
Code: CMI9316
Page number: 152
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Oncology Precision Medicine Market, By Component
  - Global Oncology Precision Medicine Market, By Care Pathway Stage
  - Global Oncology Precision Medicine Market, By Technology
  - Global Oncology Precision Medicine Market, By Biomarker Type
  - Global Oncology Precision Medicine Market, By Sample Type
  - Global Oncology Precision Medicine Market, By End User
  - Global Oncology Precision Medicine Market, By Cancer Type
  - Global Oncology Precision Medicine Market, By Reimbursement & Access Channel
  - Global Oncology Precision Medicine Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
Global Oncology Precision Medicine Market, By Component, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Therapeutics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Targeted therapies
    - Targeted biologics
    - Precision immuno-oncology
    - Cell & gene therapies
    - Radiotheranostics / targeted radionuclide therapies
    - Combination regimens
- Diagnostics / Testing
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Companion diagnostics (CDx)
    - Complementary diagnostics
    - Comprehensive genomic profiling (CGP) panels
    - Minimal residual disease (MRD) testing
    - Pharmacogenomics (PGx) relevant to oncology regimens
- Informatics & Decision Support
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Clinical decision support (CDS) / treatment matching engines
    - Variant interpretation & annotation platforms
    - Molecular tumor board (MTB) enablement software
    - Data integration (EHR/LIS/omics) & interoperability tools
- Services
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Sample logistics, biobanking, and pre-analytics services
    - Bioinformatics services (pipeline, interpretation, reporting)
    - Clinical trial matching services
    - Real-world evidence (RWE) and outcomes analytics
    - Contract research / companion diagnostic development services
Global Oncology Precision Medicine Market, By Care Pathway Stage, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Risk Assessment & Screening
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnosis & Tumor Classification
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Therapy Selection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Treatment Monitoring
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Response Monitoring
    - Resistance Emergence Detection
    - Dose/Therapy Optimization
- Recurrence Surveillance / MRD
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinical Trial Enrolment & Matching
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Global Oncology Precision Medicine Market, By Technology, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Genomics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Next-generation sequencing (NGS)
      - Targeted panels
      - Whole exome sequencing (WES)
      - Whole genome sequencing (WGS)
    - PCR / qPCR / ddPCR
    - Sanger sequencing (confirmatory)
- Transcriptomics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - RNA sequencing (RNA-seq)
    - Gene expression profiling / signatures
- Proteomics / Protein biomarkers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Immunohistochemistry (IHC)
    - Mass spectrometry–based proteomics (select settings)
- Cytogenetics & Structural Variation
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - FISH
    - Karyotyping (certain hematologic cancers)
- Epigenetics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - DNA methylation profiling (select tumors)
- Liquid biopsy technologies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - ctDNA / cfDNA
    - CTCs
    - Exosomes / extracellular vesicles (emerging)
- Single-cell & spatial
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Single-cell sequencing (scRNA/scDNA)
    - Spatial transcriptomics / multiplex imaging
Global Oncology Precision Medicine Market, By Biomarker Type, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Genetic Biomarkers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Single nucleotide variants (SNVs)
    - Indels
    - Copy number variations (CNVs)
    - Gene fusions / rearrangements
    - Germline variants (hereditary cancer)
- Genomic Signatures / Global Markers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Tumor mutational burden (TMB)
    - Microsatellite instability (MSI)
    - Homologous recombination deficiency (HRD)
- Expression / Protein Markers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Receptor status, ligand expression, immune markers (e.g., checkpoint pathway expression classes)
- Epigenetic Biomarkers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Methylation signatures
- MRD Biomarkers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Personalized tumor-informed MRD
    - Tumor-naïve MRD panels
Global Oncology Precision Medicine Market, By Sample Type, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Tissue-based
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - FFPE tissue
    - Fresh frozen tissue
    - Core needle biopsy / surgical specimens
- Blood-based (liquid biopsy)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Plasma (ctDNA/cfDNA)
    - Whole blood (CTCs, RNA)
- Other Biofluids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Urine, saliva, CSF (indication-dependent)
- Cytology Samples
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - FNA, Smears (Select Workflows)
Global Oncology Precision Medicine Market, By End User, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals & cancer centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostic laboratories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Clinical pathology labs
    - Molecular/genetic labs
- Academic & research institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pharmaceutical & biotech companies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- CROs / clinical trial networks
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Payers / HTA bodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Global Oncology Precision Medicine Market, By Cancer Type, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Solid Tumors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Lung, breast, colorectal, prostate, ovarian, melanoma, pancreatic, gastric, head & neck, liver, kidney, brain/CNS, etc.
- Hematologic Malignancies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Leukemia, lymphoma, myeloma, MDS/MPN, etc.
- Rare Cancers / Tumor-agnostic Segments
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    - Tumor-agnostic biomarker-defined populations
Global Oncology Precision Medicine Market, By Reimbursement & Access Channel, 2021-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Public Reimbursement
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Private Reimbursement
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Out-of-pocket / Self-pay
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hybrid coverage models
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Patient Assistance / Access Programs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinical trial–funded Testing
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Global Oncology Precision Medicine Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Care Pathway Stage, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Reimbursement & Access Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Care Pathway Stage, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Reimbursement & Access Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Care Pathway Stage, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Reimbursement & Access Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Care Pathway Stage, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Reimbursement & Access Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Care Pathway Stage, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Reimbursement & Access Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Care Pathway Stage, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Reimbursement & Access Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Hoffmann‑La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AstraZeneca plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol‑Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gilead Sciences Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Illumina Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- QIAGEN NV
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BioNTech SE
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Amgen Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Foundation Medicine Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Guardant Health
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Myriad Genetics Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on 'Oncology Precision Medicine Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now